The Warner Lab

In the Warner Lab, we use epidemiological methods to identify risk factors for cancer, elucidate mechanisms of action and develop strategies for eliminating racial and ethnic health disparities. 

Our goal is to identify opportunities for cancer prevention and elimination of disparities through interdisciplinary collaboration.  We wish to go from the lab bench to the doctor's office to holistically examine intrinsic and extrinsic factors that contribute to disparate health outcomes.

The largest body of our work is on breast cancer where we seek to identify risk factors for triple negative breast cancer, uncover factors that contribute to the higher incidence of these tumors among women of African descent, and identify targets for intervention to eliminate racial disparities in breast cancer survival. Our long-term goal is to ensure that all women fully benefit from the many advances made in breast cancer detection and treatment over the past 20 years.

We are based in the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital. Our work has been supported by the National Cancer Institute, the Robert Wood Johnson Foundation Seed Grant program at Harvard University, and the Alliance for Clinical Trials in Oncology.